Business Program
"Each year that I've attended the DMC, HDMA's business and policy sessions feature the latest industry research and explore the technology trends that will have the greatest impact on my company. The in-depth analysis provided in these sessions helps me plan for industry changes and future business opportunities. The DMC provides me with new ideas, insights and perspectives on best practices that I can share with others in my company."
- Neil Warren
Vice President, Industry & Supplier Relations
Cardinal Health, Inc. |
|
Expand Your Knowledge
Whether this is your first DMC & Technology Expo or your sixth, you will have unparalleled access to forums and education sessions that will address issues affecting healthcare supply chain performance. Here are a few of the exciting education topics that will be featured
this year!
Critical Industry, Policy and Regulatory Issues and Trends
Staying on the cutting-edge of public policy issues and regulatory trends is essential to enhancing your company’s efficiencies and operations. This conference features several valuable sessions
on government policies that have the most potential to affect your business.
- Medicaid AMP reimbursement update
- State licensure and inspection preparation
- Industry perspectives on new DEA trends, regulations,
and initiatives
- The latest information on federal & state
pedigree
requirements
Leading a Track-and-Trace World
Identify and explore next-level solutions that will lead to supply chain security and performance improvements. More than seven targeted sessions and case studies have been developed to share the importance of track-and-trace technologies in healthcare. A few key topics that can help companies develop strategies for the path forward include:
- EPCglobal standards for implementation
- Using EPCIS for track and trace
- Distributor & manufacturer panels on track-and-trace pilots
Ground-breaking Industry Research
The Center for Healthcare Supply Chain Research, HDMA’s knowledge partner, will lead two exciting sessions featuring ground-breaking research and must-have information for the healthcare industry. Session topics covered only at the DMC include:
- A first look at the 2008-2009 HDMA Factbook
- The Role of Distributors in the U.S. Healthcare Industry
Two Great Ways to Navigate Your Learning at DMC!
What Sessions Are Right For You?
Business discipline icons are listed by each session to help you navigate the conference and determine which sessions are right for you. Many sessions may be of interest to you from more than one discipline.
Education Sessions Key |
 |
E-Business, MIS/IT, E-commerce, Technical |
 |
Supply Chain, Operations, Logistics, Distribution |
 |
Financial, Purchasing, Contract Administration |
 |
Track & Trace, Pedigree, RFID |
 |
Government, Regulatory |
 |
Trade/Industry Relations, Sales and Marketing |
 |
HDMA & HIDA Joint Event |
 |
Audience Response Tool |
|
Level of Education Provided
New this year, the level of education provided also is identified on the schedule and in the complete session descriptions. The levels are “All Levels Welcome,” “Intermediate“ and “Advanced.”
Click on the following to see the business program for each day of the conference
Monday, June 9 | Tuesday, June 10 | Wednesday, June 11
Monday, June 9, 2008
Opening General Session
8:30 AM-9:45 AM
Welcome Address
John M. Gray, President & CEO, HDMA
HDMA President and CEO John M. Gray will officially open the 2008 DMC & Technology Expo and provide attendees with the latest information on HDMA’s
strategic advocacy efforts in the industry, in the states and on Capitol Hill. Learn more about how HDMA is working across the supply chain to achieve uniform federal pedigree requirements, more efficient and coordinated emergency response plans, industry-wide adoption of track-and-trace technologies and supply chain
best practices.
This is your chance to learn how HDMA is delivering the next levels of patient safety, business efficiency and supply chain security through ongoing initiatives with supply chain partners, lawmakers and regulators and allied trade associations.
Keynote Address: The New Competitive Challenge of Pharmaceuticals
Gary Pisano, PhD, Harry E. Figgie Jr.
Professor of Business Administration,
Harvard Business School
In facing new competitive challenges in our industry, Dr. Gary Pisano discusses the four “pillars of profitability” that previously supported extraordinary performance: 1) pricing flexibility; 2) long periods of exclusivity; 3) blockbuster product-fueled growth; and 4) relatively high levels of R&D productivity. He will delve into how each of these four pillars is being
eroded, examining the implications for the future performance of the industry and prescription medicine innovation. Pisano also will discuss corporate strategies for all segments of the healthcare
supply chain.
Dr. Pisano is the Harry E. Figgie Jr. Professor of Business Administration at the Harvard Business School. Since joining the Harvard faculty in 1988, he has taught both MBA- and executive-level courses on technology and operations management, operations strategy, competitive strategy, product development, the management of innovation and healthcare. He is a widely-published author with more than 25 research papers in journals, such as Management Science, Administrative Science Quarterly and Harvard Business Review.
Dr. Pisano has served as an advisor to senior managers at many companies, assisting them in creating business and operating strategies and in improving product development performance. He holds a PhD from the University of California, Berkeley, and a BA in Economics from Yale University.
Concurrent Education Sessions | 10:00 AM-11:00 AM
Industry Adoption Roadmap: EPCglobal Healthcare Standards
Level: Intermediate
What are the pros and cons of using 2D barcodes and RFID to track-and-trace prescription medicines? What is the current status of these and other standards? Find answers to these questions and more during this intermediate-level session. Specifically, attendees will gain a better understanding of the key issues and action steps companies will need to evaluate as they work to implement track-and-trace technologies throughout internal organizations, and across the entire supply chain. Attend this session to learn more about the action steps for item-level serialization and track-and-trace technology implementations, and the impact of your company's decisions on costs, supply chain security and the operational efficiencies of trading partners both up and downstream.
Speaker: Ted Ng, Director, Director, BTS Architecture and Strategy Group, McKesson Corporation
The Aftermath of AMP: What’s Next?
Level: Advanced
The Deficit Reduction Act of 2005 resulted in sweeping revisions to the Average Manufacturer Price (AMP), the reimbursement metric used to set Medicaid payments to pharmacists. CMS also revised its regulation for Medicare Part B drugs, governing the determination of the Average Sales Prices (ASP) reimbursement metric. This session will provide an update on the Medicaid AMP Final Rule since it went into effect July 2007, reviewing the industry’s responses through CMS’s extended public comment period. This session will discuss the status of the publication of AMP data under the Final Rule, issues resolved since the expiration of the extended comment period, as well as the status of pending AMP litigation. The session also will examine the status of federal legislative initiatives aimed at revising key elements of the ASP metric.
Speaker: Larri Short, Esq., Partner, Health Law Group, Arent Fox, PLLC
Get More Out of EDI: Building Your
E-Commerce Strategy
Level: Intermediate
Attend this session to learn more about the newly-updated EDI transaction sets, including those for contracts and chargebacks (844, 845, 849) and product transfers and resale (867). Hear from experts on how these updated EDI transaction sets can help streamline and simplify many business processes and help build more robust e-commerce capabilities. Attendees also will learn how to analyze trading partner data using EDI, and incorporate data into internal reporting mechanisms.
Speakers: Susan M. Lowe, Senior Business Analyst, McKesson Corporation; and Debby K. Yaudes-Brown, Senior System Analyst, GlaxoSmithKline
New Session Added!
GLN 101 - Introduction to Global Location Number
Level: All Levels Welcome
Learn about the identification and management of location identification information using the GSI Global Location Number (GLN) and the GLN Registry. Unique location identification is important for understanding e-commerce applications, supply chain management and pedigree/track-and-trace. Get an overview of GLNs, including the benefits of the applications and their real-world implementations.
Speaker: John J. Roberts, JD, Director Healthcare BCEC, GS1 US
Concurrent Education Sessions | 11:15 AM-12:15 PM
A First Look at the 2008-2009 HDMA Factbook: Emerging Industry Trends
Level: All Levels Welcome
Take a guided tour of emerging trends in the healthcare supply
chain. The Center’s Benchmarking Research Committee members will provide an exclusive first look at the latest industry benchmarks to explore distributor financial performance, productivity, operations and healthcare market characteristics. The session will feature in-depth analyses of industry changes, and forecast important future implications. Get the latest facts, figures and trends to drive your company forward!
Moderator: Joseph Perri, Regional Director, Finance, AmerisourceBergen Drug Company
Panelists: James F. Meehan, Vice President, Sales, Marketing & Distribution, Ranbaxy Pharmaceuticals, Inc.; Ed Vianco, Vice President, Controller, McKesson Corporation; Bob Weston, Customer Service/Logistics Manager, Procter & Gamble Pharmaceuticals
Looking Forward in Reverse Logistics:
Data Synchronization
This session is closed to the media to provide an
open forum for industry professionals.
Level: Advanced
This session will provide a deeper understanding of the data elements used to communicate information about reverse logistics product flow. Common definitions and units of measure for 12 key data elements shared in the debit memo, return authorization and shipping manifest business processes will be discussed. Hear fresh perspectives from industry experts from the HDMA Returns Task Force in this advanced-level session.
Facilitated by: Chris Quinn, Vice President, Sales & Marketing, GENCO Pharmaceutical Services
Speakers: Chris Doerr, Senior Manager, A/R & Credit, Cephalon, Inc.; Frank Harkins, Associate Director, Credit & Collections, Boehringer Ingelheim Pharmaceuticals, Inc.; and Amy Plourde, Manager, Manufacturer Returns, AmerisourceBergen Drug Company
Going Green by Connecting Warehousing Technologies & Sustainability
Level: Intermediate
Take a holistic look at your current warehousing operations and evaluate new processes that promote the long-term well-being of the environment, society and the bottom line. Understanding the connection between your carbon footprint and your corporate image, and between Leadership in Energy and Environmental Design (LEED) Certification and more efficient lighting or HVAC, is the gateway to your “green” warehousing strategy.
Speaker: Fran Charland, Vice President, Strategies and Solutions
New Session Added!
California Pedigree Update
Level: Intermediate
As a result of a scheduling conflict, Virginia Herold, Executive Director, California Board of Pharmacy, unfortunately will not be able to participate in the HDMA 2008 DMC & Technology Expo. However, Herold's PowerPoint presentation will be available for attendees. To download her presentation, please click here.
California Pedigree Session Update! This session has been changed to explore California’s track-and-trace requirements, including the current political climate, now that the implementation deadline for electronic pedigree has been extended to January 1, 2011. Learn more about what’s required under the current law, as well as potential legislative changes that may be enacted as early as this year. Learn about how the supply chain is preparing for implementation, as well as technical recommendations, detailed in HDMA’s Baseline Technical Recommendations for Compliance With California's Requirements.
Newly Added Speakers: Ron Bone, Senior Vice President, Distribution Support, McKesson Supply Solutions;
Elizabeth A. Gallenagh, Senior Director, State Government Affairs, HDMA; and
John G. Howells, Senior Director, Industry Relations, HDMA
Concurrent Education Sessions | 2:15 PM-3:15 PM
Enabling Track & Trace With EPCIS
Level: Intermediate
A key driver of track-and-trace implementation will be EPCIS (Electronic Product Code Information Services), an EPCglobal standard for describing, capturing and sharing serialized product data in the supply chain. This session will focus on the various features of EPCIS to improve patient safety and supply chain security. Learn more about how EPCIS forms the cornerstone of data management/data sharing, as detailed in The Rules of Engagement: Phase II • The Blueprint for Data Management & Data Sharing. Learn how to utilize this technology to meet current and emerging state and federal pedigree requirements.
Speakers: Daniel G. Hernandez, IBM WebSphere RFID Information Center, IBM; Russell McGarrity, Manager, Pharmaceutical Information Systems, Procter & Gamble Pharmaceuticals; and Heather Zenk, PharmD, Director, Integrated Solutions, AmerisourceBergen Corporation
A View From the DEA: Trends, Regulations & Interpretations
This session is closed to the media to provide an
open forum for industry professionals.
Level: Intermediate
At this informative session, hear from the Drug Enforcement Administration (DEA) as they give their perspectives on current enforcement trends; planned and upcoming regulations; new interpretations of existing regulations; and insight into Agency policies. Find out about potential new DEA initiatives and the companies that may be affected. Attendees will have ample opportunities to ask questions during the session—either directly or confidentially.
Speaker: Mark Caverly, Chief Liaison and Policy Section, Office of Diversion Control, DEA
Preparing for Pandemic: An Industry Response
Level: Intermediate
Public-private partnerships across all levels of government, industry and public health organizations are focused on emergency preparedness and pandemic response planning. This session will provide a summary of various government efforts and plans, and will detail the healthcare distribution industry’s initiatives with the RxResponse pandemic plan. Attendees will have the opportunity to participate in a mock exercise, followed by a discussion of the important decisions and industry communications that are critical to effectively managing a pandemic event.
Speaker: Erin Mullen, RPh, PhD, Assistant Vice President, Rx Response, PhRMA; Ann Peterka, DO, MPH, Director, Employee Health Services, Hoffman-La Roche; and
Isaac K. Rogers, Director, Organization Development, Smith Drug Company
New Session Added!
Congress, Generics & Biologics: The Continuing Debate
Level: Intermediate
Generic prescription medicines and therapeutic biologics are the fastest growing segments in the U.S. healthcare industry. There currently is no regulatory pathway for the introduction of generic/follow-on biologics into this marketplace. Congress appears ready to tackle this issue, hoping to both increase healthcare savings while maintaining incentives for medical innovation. Given the complex scientific, legal and political matters at stake, will this be the year legislation is put into place? Attend this session to hear leading experts from both sides of this timely debate as they outline their industry’s positions and share their political prognoses for Congressional action this year.
Speakers: Brent A. Del Monte, Vice President, Federal Government Relations, Biotechnology Industry Organization (BIO); and Jason R. Money, Director of Government Affairs, Generic Pharmaceutical Association (GPhA)
Concurrent Education Sessions | 3:30 PM-4:30 PM
Manufacturer Insights: Getting Started With
Track & Trace
Level: Intermediate
Learn about the challenges, opportunities and lessons learned in implementing track-and-trace technologies from a manufacturer perspective. This informative session will present an approach to adoption based on findings from one company’s pilot program.
Speaker: Nelson Bermudez, Executive Director, Global Distribution, Amgen Inc.; and Ronald S. Yakubison, Associate Director, Packaging Facilities & Equipment Technology, Merck & Co, Inc.
Cold Chain Best Practices
Level: Intermediate
With the increasing number of products that require cold chain handling, the HDMA Logistics Operations Committee has been working to develop best practices for distributing these unique products. In this session, learn about handling cold chain products at the point of receipt, and how to best maintain proper storage conditions in the distribution center. Attend this session to learn more about how distributors can demonstrate enhanced business value by providing cold chain handling services, which are quickly becoming a top service offering sought by all trading partners.
Speaker: Timothy L. Garten, Vice President, Operations, McQueary Bros. Drug Co.
How to Prepare for a State Licensure Inspection
This session is closed to the media to provide an
open forum for industry professionals.
Level: Intermediate
This informative and relevant “how to” session will provide information and practical tools distributors can use to support a successful state licensure inspection process. Discussions will focus on state regulator and private sector inspections and describe strategies to help prepare for an audit. Attend
to learn how to efficiently comply with the varying state
licensure requirements.
Speakers: Steve Hudson, Accreditation Manager, National Association of Boards of Pharmacy; and Ronald W. Buzzeo, RPh, Chief Regulatory Officer, Compliance Solutions, BuzzeoPDMA
Tuesday, June 10, 2008
Tuesday Morning General Session
8:30 AM-9:45 AM
What’s In, What’s Out, What’s Ahead:
2008 Healthcare Marketplace Trends
Doug Long, Vice President, Industry Relations, IMS Health
Get the first look at the latest industry data and emerging market trends for branded pharmaceutical, generic pharmaceutical and health & beauty care product sales from Doug Long of IMS Health. Long is an industry thought leader who analyzes information from IMS Health’s premier sales, prescription, promotional and medical databases. Using this data, he is able to offer perspectives on a range of vital pharmaceutical topics, including global market trends, industry forecasts, research and development, marketing practices, blockbuster drugs, patent expirations and generic trends, biotechnology and more. Take advantage of this opportunity to learn how emerging trends will have an impact on strategic business plans for the coming year—and beyond.
Doug Long is Vice President of Industry Relations at IMS Health. He is charged with developing information for data partners, and managing supplier, manufacturer and association relationships. Long has considerable experience with the changing U.S. and global healthcare marketplaces, as well as insight into healthcare distribution, which gives him a unique perspective. Prior to IMS Health, Long worked at Nielsen Market Research for 16 years in various sales and marketing capacities. Long received a BA from DePauw University, and an MBA in Management from Fairleigh Dickinson University.
Concurrent Education Sessions | 10:00 AM-12:00 PM
Federal & State Pedigree Update
Level: Intermediate
Current pedigree requirements vary state by state, and continue to evolve as more legislatures update and revise existing laws. In addition, pedigree legislation has been introduced at the federal level that could dramatically alter the way prescription medicines are tracked and traced through the supply chain. In this session, learn more about the varying pedigree requirements at the state level, as well as new proposed federal pedigree models. The latest trends and outlooks for pedigree and licensure will be discussed, as well as information on unique state approaches.
Speakers: Elizabeth A. Gallenagh, Esq., Senior Director, State Government Affairs, HDMA; Anita T. Ducca, Senior Director, Regulatory Affairs and Healthcare Policy, Healthcare Distribution Management Association; and Joe Trauger, Senior Director, Federal Government Affairs, HDMA
Contract Administration: Streamlining the Customer Conversion Process
Level: Advanced
Back by popular demand, this interactive discussion forum will provide practical strategies to streamline contract administration and chargeback processes! When customers change distributors or group purchasing organizations (GPOs), a series of complex processes are triggered. This interactive session will include a panel discussion of the customer conversion process and provide a real-world example of process improvement in contract administration. Find out how to eliminate duplication of redundant work and verify customer data.
Speaker & Panel Moderator: Heather McCreary, Director of Contracts & Supplier Strategy, AmerisourceBergen Corporation
Panelists: Joseph F. Brundza, Director, Contract Administration, Hospira Worldwide, Inc.; David Evangelista, Director, Contract Administration, McKesson Supply Solutions; Tom Kowalski, Director, Corporate Contracts, Chargebacks Operations, Pharmaceutical Supply Chain, Cardinal Health, Inc.; Sammie Jo McCune, Contract and Chargeback Administrator, McQueary Bros. Drug Co.; and Eric Shaw, Vice President, Distribution Services, Broadlane
Six Sigma Logistics: Applications in Healthcare
Level: Advanced
Healthcare is a highly-regulated business with varying state requirements. However, most healthcare companies are seeking new ways to standardize and streamline business processes in order to reduce waste, increase productivity and reduce cost. Linking lean supply chain management with Six Sigma logistics is a potential strategy that can be used further to optimize supply chain operations. Designed especially for distributors but applicable for all supply chain partners, this topic will be presented by experts in the field of Six Sigma logistics.
Speakers: Ron Hoelzer, Director, Operations, H. D. Smith; and Steve Gran, Principal, Blueprint 57
Concurrent Education Sessions | 1:30 PM-2:30 PM
Distributor Insights: Implementing
RFID/Track & Trace
Level: Intermediate
Attend this session to learn about current and future challenges, potential opportunities and lessons learned from distributor pilot programs. Explore innovative approaches to implementing track-and-trace technologies, and gain key takeaways to use in your company’s adoption planning strategy.
Speakers: Robert E. Kashmer Jr., Vice President, Information Technology, H. D. Smith; and Heather Zenk, PharmD, Director, Integrated Solutions, AmerisourceBergen Corporation
DEA Regulatory Update: An Industry Perspective
This session is closed to the media to provide an
open forum for industry professionals.
Level: Intermediate
This second DEA-focused session will provide attendees with an overview of the existing legislation and regulations designed to further secure the safety and security of controlled substances. This industry panel will focus on recent findings and trends in DEA inspections, and discuss specific examples to highlight DEA’s changing regulatory and enforcement paradigm. Requirements for meeting DEA regulations regarding suspicious orders also will be discussed.
Speaker: David L. Durkin, Esq., Principle, Ollson Frank Weeda Terman Bode Matz PC
New Session Added!
The Power of One: Unique Location Identification
Level: All Levels Welcome
In the healthcare supply chain, a variety of numbering schemas are used to identify locations in the supply chain, including DEA, HIN, DUNS, GLN and more. However, unique location identification is becoming more critical as companies work to streamline business processes and standardize the way manufacturers and distributors identify retail, hospital, clinic and other pharmacy delivery points. In this session, you will learn about HDMA’s Business Technology Committee’s (BTC) efforts to adopt a single unique location identifier in healthcare. This is an audience participation session, so come prepared to provide input on the numbers currently used by your organization, and the possible use of a single identifier across the industry!
Speakers: Jeffrey W. Denton, Director, IT, Supply Chain Management, AmerisourceBergen Drug Company; and
Ted D. Lyjak, Director of Trade Sales, Hospira Worldwide, Inc.
The Role of the Distributor
Level: Intermediate
The healthcare supply chain has evolved over the last three years to become healthier and more efficient, according to the recently updated The Role of the Distributors in the U.S. Healthcare Industry. The Center for Healthcare Supply Chain Research’s study, conducted by Booz & Company, documents the growth of the industry, as well as the role and value of healthcare distributors. In this fast-paced session based on quantitative analyses, attendees will take a deeper look at today’s healthcare marketplace, and learn more about the $34 billion in savings and value delivered by primary healthcare distributors. Attendees also will become more familiar with potential marketplace changes that could impact the future.
Speaker: Alan Kierstead, Partner, Booz & Company
Wednesday, June 11, 2008
Wednesday Morning General Session
8:30 AM-9:30 AM
A View From the Customer: Panel Discussion
The healthcare supply chain exists to safely and efficiently serve more than 144,000 pharmacy settings across the United States. Distributors and manufacturers work together every day to find opportunities to reduce costs and enhance services. But, it is the needs of the various customers—and ultimately the patients —that drive business. This panel discussion, moderated by industry veteran Bob Dufour, will provide a look into customer expectations, needs and fears, and will explore how customers view working with the supply chain.
Panel Moderator: Bob Dufour, Senior Manager, Health Sciences Advisory Services Pharmacy Practice, Ernst & Young, LLP
Bob Dufour is Senior Manager at Ernst & Young, working in the Health Sciences Advisory Services (HSAS) Pharmacy practice. Dufour is a pharmacist with 24 years of experience at Wal-Mart. He has extensive experience working within the pharmacy industry covering a broad variety of issues, including mail order pharmacy, pharmacy operations, specialty pharmacy, PBMs, third-party contracting, manufacturer programs, professional services and government relations.
Dufour currently is the President of the Arkansas Board of Pharmacy. He has received numerous awards and is recognized as a leader in the retail pharmacy industry. Dufour received his BS in Pharmacy from the School of Pharmacy, University of Louisiana at Monroe.
Panelists: Tony Welder, Owner, Dakota Pharmacy; Rebecca Shanahan, Shanahan Capital Ventures; Mike Leblanc, Director of Business Development, Pharmacy, Winn Dixie; and Mark de Bruin, Executive Vice President of Pharmacy, Rite Aid
Closing General Session
9:45 AM-11:00 AM
Sabato’s Crystal Ball: 2008 Election Insights
Larry Sabato, PhD, Election Analyst & Professor, University of Virginia
The 2008 Presidential election is shaping up to be one of the most exciting and important in U.S. history, as the candidates develop and voice their positions on the issues affecting America’s future. The election’s outcome will influence company strategies and opportunities for years to come, which is why it is critical to know more about the candidates—and their platforms—as
they develop.
Lauded as “the Dr. Phil of American Politics” by The Washingtonian, Dr. Sabato was named the most accurate prognosticator of 2006 by FOX News, MSNBC, CNBC and Pew’s Project for Excellence in Journalism. The author of more than 20 books and countless essays on politics, Dr. Sabato also has served on many national and state commissions, and is the recipient of more than two dozen major scholarships, grants and academic awards. He is a chaired Professor of Politics at the University of Virginia and Director of the UVA Center for Politics, founded
in 1998 to improve civic education and the political process.
His latest book, A More Perfect Constitution: 23 Proposals to Revitalize Our Constitution and Make America a Fairer Country, was released in 2007. He also started “Sabato’s Crystal Ball,” a Web site dedicated to the analysis and prediction of the upcoming Governor, House, Senate and Presidential races.
|
